Abstract
This commentary places the contributions from several Asian–Pacific countries that constitute this Special Issue in the context of trends in global regulation of tissue engineering and regenerative medicine products and services. It concentrates on the generic issues that face regulation in each jurisdiction and the manner how these issues have to be faced in the light of cultural, political, and economic regional differences.
Get full access to this article
View all access options for this article.